IDEAYA Biosciences Inc. (IDYA)
NASDAQ: IDYA
· Real-Time Price · USD
27.16
1.33 (5.15%)
At close: Sep 05, 2025, 3:59 PM
28.50
4.93%
After-hours: Sep 05, 2025, 07:43 PM EDT
5.15% (1D)
| Bid | 25.7 |
| Market Cap | 2.38B |
| Revenue (ttm) | 7M |
| Net Income (ttm) | -331.03M |
| EPS (ttm) | -3.85 |
| PE Ratio (ttm) | -7.05 |
| Forward PE | -7.83 |
| Analyst | Buy |
| Ask | 27.91 |
| Volume | 1,617,168 |
| Avg. Volume (20D) | 1,022,975 |
| Open | 25.88 |
| Previous Close | 25.83 |
| Day's Range | 25.88 - 27.18 |
| 52-Week Range | 13.45 - 37.99 |
| Beta | 0.09 |
About IDYA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IDYA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IDYA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
IDEAYA Biosciences Inc. is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+3.79%
IDYA stock has given up its prior gain. Ideaya Bio...
Unlock content with
Pro Subscription
4 days ago
+3.79%
Ideaya Biosciences shares are trading higher after the company announced an exclusive license agreement with Servier for Darovasertib for rare eye cancer.
